SDIC Venture Capital

SDIC Venture Capital Management Co., Ltd., established in 2016 and based in Beijing with an additional office in Shanghai, is a principal investment firm focused on advancing national strategic industries in China. It specializes in sectors such as smart manufacturing, integrated circuits, artificial intelligence, network information security, new materials, consumerism, information technology, environmental protection, new energy, biopharmaceuticals, and healthcare. The firm manages four funds, with total assets under management amounting to RMB 14 billion. SDIC Venture Capital aims to facilitate the marketization and industrialization of scientific and technological achievements while aligning with national innovation strategies. By investing in key research directions and supporting technological innovation, the firm seeks to implement national development strategies and foster collaboration among government, society, and market entities.

Dechun Chen

Vice President

Zhong Guodong

Vice President

Meng Qian

Vice President

Li Ruge

Chief Financial Officer

Du Wenmin

Vice President

Yang Xiaohui

Vice President

Hua Zhang

Chief Financial Officer

91 past transactions

Zhishan Weixin Biotechnology

Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Viiyong

Series B in 2022
Viiyong is a manufacturer of multi-layer ceramic chip capacitors.

Dakang Medical

Series E in 2022
Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

TBSTest

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of integrated circuit automatic test equipment, specializing in solutions for semiconductor manufacturers. Founded in 2017 and headquartered in Beijing, China, with additional offices in Xi’an City, Shanghai, and Suwon, South Korea, the company offers a range of products including test boards, software solutions, and memory systems. TBSTest Technology also provides pre-sales and after-sales support for its equipment, accessories, and software systems, catering to clients in integrated circuit design and production, as well as scientific research institutions and educational organizations. The company is dedicated to advancing testing technology for ultra-large-scale integrated circuits, ensuring high-quality performance for enterprise users in the semiconductor industry.

Yihui Information

Series B in 2022
Yihui Information is a high-tech enterprise with complete independent intellectual property rights

G7

Private Equity Round in 2022
G7 has an installation base of 800,000 cargo vehicles throughout China. Through its proprietary hardware devices, the company is able to compile data for logistics companies and drivers on location, route optimization, fuel consumption, and cargo status (temperature, humidity, etc).

Ractigen Therapeutics

Series A in 2022
Ractigen is an early-stage pharmaceutical company committed to bringing to market first-in-class therapies designed to selectively restore the expression of therapeutic genes silenced in diseased cells. Its core technology is based on a paradigm-shifting discovery made at the University of California San Francisco (UCSF) known as RNA activation (RNAa). Founded in 2016 by the pioneers in the field, Ractigen is developing a rich pipeline of candidate medicines for patients with unmet need.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.

Aluksen Technology

Series B in 2022
Aluksen Technology is an industry leading semiconductor chip manufacturer specializing in optoelectronic technology. The R&D center is located in Silicon Valley, USA. We focus on the telecom, industrial and consumer electronics markets, and gradually form a marketing and service network with Shenzhen as the operation center and covering the global region. We will continue to innovate around customer needs and strive to provide high customers. Quality products and fast, professional technical support and services.

Gongda Satellite

Series A in 2021
Gongda Satellite is a commercial aerospace company that designs, manufactures on-orbit delivery commercial satellite products.

MoonBiotech

Series C in 2021
Guangzhou Based Healthcare Start up.

Jinyi New Material

Venture Round in 2021
Ginet New Material is a technology company providing R&D and production of inorganic non-metallic powder new material application solutions.

Time Speed

Series B in 2021
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Sinomicro Medical

Series C in 2021
Sinomicro Medical is a medical device firm focused on the development of tumor ablation treatment with minimally invasive surgical robots.
The founding team of Vipas Semiconductor is composed of high-tech technical experts and market management experts from home and abroad. Relying on Nanjing University's independent innovation of vertical charge transfer imaging device (VPS) technology, it focuses on a new generation of new sensor imaging chip technology products. A high-tech company that develops and manufactures.

Immunochina

Series D in 2021
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Guangdong Xinjuneng

Venture Round in 2021
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Bo Shi Ran

Venture Round in 2021
Bo Shi Ran is a cotton harvester that provides mechanized solutions for cotton planting, integrating R&D, production, sales, and service.

Inceptio Technology

Series B in 2021
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

SVOLT

Series B in 2021
Svolt Energy Technology Co., Ltd. is a high-tech new energy company that specializes in energy technology, including electric vehicle battery (EVB) materials, cells, modules, PACK, BMS, energy storage system (ESS) and solar energy R&D and manufacturing. Headquartered in Wuxi, Jiangsu, SVOLT plans for 7 R&D centers around the globe, with four currently in operation, in Baoding, Korea, Shanghai and India, and three are under construction in the US, Japan and Wuxi. Domestically, SVOLT’s factory is under construction in Changzhou, Jiangsu, which will be operational by the end of 2019 with SOP in February 2020, and will have a capacity of 12GWh in 2020. Roadmap: SVOLT is pioneering the introduction of prismatic stacking batteries, making it the world’s first high-speed stacking prismatic battery maker. SVOLT aims to finish stacking one cell in 0.25 seconds in one single station. In contrast to the same type of winding process, the energy density of SVOLT stacking batteries improves 5%, the cycle life improves 10% and the cost reduces 15%.

Huitongda

Series E in 2021
Huitongda Network Co., Ltd. is a Chinese logistics service provider focused on supplying household appliances to rural markets. Established in January 2008 and headquartered in Nanjing, the company combines online and offline sales strategies to support retail outlets and enhance e-commerce penetration in township areas. Huitongda specializes in categories such as air-conditioning, color TVs, refrigerators, and washing machines, and it has trained over 3,000 retail outlets across Jiangsu, Shandong, and Anhui provinces. By facilitating the sale of goods to rural customers and providing essential infrastructure for e-commerce, Huitongda plays a significant role in bridging the gap between urban product availability and rural consumer demand. The company operates as a subsidiary of Jiangsu Five Star Appliance Co., Ltd.

Porton Advanced Solutions

Series A in 2021
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Abogen Biosciences

Series B in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Aucta Pharmaceuticals

Series A in 2021
Provider of a drug development platform intended to improve drug delivery and develop novel and niche generic medical products. The company's drug development platform is poorly water soluble, features controlled release and specializes in central nervous system and oncology compound, enabling pharmaceuticals companies to develop drugs and drug-based products based on patient compliance.

BGI Tech

Post in 2021
BGI Tech Solutions Co., Ltd., founded in 2012 and headquartered in Shenzhen, China, is a leading biotechnology company specializing in advanced life sciences technology. The company offers a wide range of services, including bioinformatics, genetic testing, and agricultural genomics research. BGI Tech operates lab facilities in Hong Kong, Wuhan, and Sacramento, and has a global service network that spans over 100 countries and regions. With collaborations involving more than 10,000 organizations and 30,000 partners, BGI Tech supports numerous research projects, including large-scale international genome initiatives. The company is committed to developing integrated omics platforms and aims to address various challenges in health, agriculture, energy, and environmental sectors, thereby contributing to scientific advancement and improving societal well-being.

Tianfu

Series B in 2021
Nanjing Tianfu Software Co., Ltd. develops custom software solutions for various industries, such as turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. The company founded in 2011 and is based in Nanjing, China.

Jaka Robot

Series C in 2021
Jaka Robot develops, engineers, manufactures, and markets industrial robots. Its products include JAKA ZuTM robot, which is a wireless control system that collaborates with mobile applications; JAKA MES, which helps in information integration across various departments in a factory; conveyor systems; palletizing robot systems; and liner molding machines. The company caters to food and beverage, chemical, packaging, electronics, and mechanical processing industries. The company was founded in 2014 and is based in Shanghai, China.

Zhiyi Pharmaceutics

Series B in 2020
Zhiyi Pharmaceutics Inc., a biopharmaceutical company, is engaged in research and development of NGPs (next-generation probiotics) and LBPs (live biotherapeutics). The company’s products include SK08, TP2, ZY19, and SK09. Its products can be used for treating gastrointestinal disorders. Zhiyi Pharmaceutics Inc. was founded in 2013 and is headquartered in Guangzhou, China.

Abogen Biosciences

Series A in 2020
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

WM Motor

Series D in 2020
WM Motor is an automotive company that designs, manufactures, develops, and markets energy and battery-operated vehicles. It provides energy vehicle products and travel solutions to its customers. The company aims to conserve electronic vehicles in addition to intelligent data hardware, enabling consumers to utilize smart cars that are efficient and energy conserving. WM Motor’s products are built with three core technologies, the Living Motion electric powertrain, the Living Pilot intelligent driving assistance system, and the Living Engine operating system, which offers industry-leading smart connectivity and interactive features.

Biocytogen

Series D in 2020
Biocytogen is a biotechnology company specializing in the development of gene-engineered animal models for life sciences research. Founded in 2008 and headquartered in Beijing, with additional locations in the United States, Biocytogen offers a range of preclinical animal studies utilizing various advanced models, including gene humanized and patient-derived xenograft (PDX) models. Its product portfolio features numerous genetically modified mouse and rat models designed for research in areas such as tumor immunity, autoimmunity, and pharmacology. The company also provides customized gene-targeting services, phenotype analysis, and an antibody research and development platform. By integrating resources from both China and the U.S., Biocytogen aims to be a leading supplier of gene-targeted animal models and services globally.

XuanZhu Pharma

Series A in 2020
Shandong Xuanzhu Pharmaceutical Technology Co., Ltd. is engaged in pharmaceutical research and development. The company conducts pharmacodynamics and pharmacokinetic analysis,a process in which it screens, designs and matches chemical compounds, analysing the effect of drugs on the human body and their absorption rates. The company is based in China.

Everbright Photonics

Series C in 2020
Everbright Photonics is a company based in Suzhou that specializes in the research, development, manufacturing, and sales of core components for the laser industry. Their product offerings include semiconductor laser chips, devices, and modules, positioning them as a key player in the smart hardware sector. Through their focus on innovation and technology, Everbright Photonics aims to advance the capabilities and applications of laser technology in various fields.

BYD

Venture Round in 2020
BYD Company Limited, headquartered in Shenzhen, China, is a diversified enterprise engaged in the research, development, manufacture, and distribution of various products, primarily focusing on rechargeable batteries, automobiles, and mobile phone components. The company operates through three main segments: rechargeable batteries and photovoltaic products, mobile handset components and assembly services, and automobiles. BYD produces lithium-ion and nickel batteries for portable electronic devices, along with components such as casings and keypads for mobile phones. In the automotive sector, BYD offers a wide range of vehicles, including passenger cars, buses, taxis, and specialized vehicles for logistics and construction. Additionally, the company is involved in property development and management services. Founded in 1995, BYD has established itself as a key player in the global market for electric vehicles and renewable energy solutions.

DTStack

Series B in 2019
Kangaroo Cloud (quasi-unicorn enterprise) owns two digital technology subsidiaries, cloud technology and cloud technology, mainly for retail, finance, government, tourism, internet and other industries, providing digital stacks including DTinsight, data visualization, and data center solutions. Big data and cloud technology products and services, including solutions and cloud MSPs, help companies achieve digital transformation and promote industrial innovation and social progress.

HQ Education

Series A in 2019
HQ Education is an O2O education service platform.

Remegen

Private Equity Round in 2019
RemeGen, Ltd. ("RemeGen") is a biopharmaceutical company in China dedicated to fulfilling unmet medical needs for patients with life-threatening conditions. RemeGen's main focus is research and development, manufacturing and commercialization of novel biologics, most notably monoclonal antibodies (mAb) and antibody-drug conjugates (ADCs). Headquartered in Yantai, Shandong Province, China, RemeGen has labs/offices in Beijing and California.

PhotonIC Technologies

Series C in 2019
PhotonIC Technologies is an optoelectronic integrated circuit chips provider. PhotonIC Technologies focus on designing, developing, and commercializing high-speed/low-power optoelectronic integrated chips for data center, 5G transmission, 3D ToF smart sensing and other fields.

Casiris

Series D in 2019
Casiris Vision is a limited liability company jointly invested by the Institute of Physics and Chemistry of the Chinese Academy of Sciences, Hangzhou Economic and Technological Development Zone, venture capital and technical team. The company is committed to R&D and production challenges. A pure laser display product with a human visual limit. In 2016, it was recognized as a national high-tech enterprise, a high-tech enterprise in Hangzhou, a technology-based enterprise in Zhejiang and Hangzhou Economic and Technological Development Zone. At present, Zhongke Aurora has 5,500 square meters of automated light source and complete machine production line, providing laser light source applications to home theater, engineering projection, film and lighting engineering complete solutions.

Biocytogen

Series D in 2019
Biocytogen is a biotechnology company specializing in the development of gene-engineered animal models for life sciences research. Founded in 2008 and headquartered in Beijing, with additional locations in the United States, Biocytogen offers a range of preclinical animal studies utilizing various advanced models, including gene humanized and patient-derived xenograft (PDX) models. Its product portfolio features numerous genetically modified mouse and rat models designed for research in areas such as tumor immunity, autoimmunity, and pharmacology. The company also provides customized gene-targeting services, phenotype analysis, and an antibody research and development platform. By integrating resources from both China and the U.S., Biocytogen aims to be a leading supplier of gene-targeted animal models and services globally.

Bangsun Technology

Series C in 2019
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

Allist Pharmaceuticals

Series A in 2019
Shanghai Allist Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the discovery, development, and commercialization of products aimed at improving human health. Established in 2004 and based in Shanghai, China, the company offers both generic and branded pharmaceuticals, specifically targeting treatments for cardiovascular diseases, acid-related disorders, and cancer. Allist Pharmaceuticals is recognized for its innovative approaches, particularly in the field of cancer treatment, and operates both domestically and internationally to expand its reach in the pharmaceutical market.

Intelligent Laser

Series B in 2019
Intelligent Laser is a developer of robotic laser vision systems, mainly engaged in the development and production of laser vision systems. At the same time, it cooperates with Tangshan Yinglai Machine Vision Engineering Technology Application Center to provide users with solutions for laser vision sensors for industrial robots.

NationalChip

Series B in 2019
Hangzhou Nationalchip Science&Technology Co, Ltd. focuses on IC design and system solution development in the fields of digital television, home multimedia, and artificial intelligence (AI). The company offers demodulator, and decoder and video post processing IC series, as well as demodulator, decoder, and video post processing SoC IC solutions for satellite, cable, terrestrial, and mobile transmitted DTV areas. It also provides embedded SoC chip designed for AI, IoT, AI voice, and intelligent voice front-end signal processing applications, as well as YOC solutions. The company was founded in 2001 and is based in Hangzhou, China.

Biostar Technologies

Series B in 2019
Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

MabPlex International

Series A in 2019
MabPlex International Ltd provides contract development and manufacturing of biopharmaceuticals including, monoclonal antibodies (mAbs), recombinant proteins, Antibody Drug Conjugates (ADCs) and bispecifics. It offers customized mammalian cell medium, cell banking, monoclonal antibodiy active pharmaceutical ingredient (API) manufacturing, and biologics and ADC fill and finish manufacturing. The company was founded in 2013 and is based in Yantai, China with an additional office in Fremont, California.

BrightGene

Venture Round in 2019
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.

ZettaStone

Angel Round in 2018
Beijing Zettastone Technology Co., Ltd. is a company based in Beijing, China, specializing in the development of solid-state drives (SSDs). The company focuses on creating SSDs that cater to the needs of personal computer manufacturers, data centers, and storage solution providers. By providing advanced storage technology, Zettastone aims to enhance performance and efficiency for its customers, offering solutions that are both easier to use and faster than traditional storage options.

Everbright Photonics

Series B in 2018
Everbright Photonics is a company based in Suzhou that specializes in the research, development, manufacturing, and sales of core components for the laser industry. Their product offerings include semiconductor laser chips, devices, and modules, positioning them as a key player in the smart hardware sector. Through their focus on innovation and technology, Everbright Photonics aims to advance the capabilities and applications of laser technology in various fields.

Changhong Intelligent

Series B in 2018
Jiangsu Changhong Intelligent Equipment Group Co., Ltd., founded in 1989 and based in Yancheng, China, specializes in designing and manufacturing production lines for the automotive sector. The company provides comprehensive services including planning, design, installation, and after-sales support for welding, coating, and final assembly production lines. Its offerings encompass various systems such as auto-body assembly lines, coating lines, and interior trims assembly, catering to automotive, aerospace, and general industry sectors. Covering 280,000 square meters with a building area of 150,000 square meters, Changhong employs over 600 staff and has established a National-Level Postdoctoral Scientific Research Workstation and an Enterprise Technical Center. The company is recognized as a key hi-tech enterprise and has received multiple awards for its innovative products, including painting robots and advanced conveyor systems. Changhong also maintains partnerships with academic institutions like Tsinghua University to advance research and development, reinforcing its position as a leader in automated manufacturing technology.

Cambricon Technologies

Series B in 2018
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

Robotleo

Series B in 2018
Robotleo manufactures robots for domestic use. The company was founded in 2014 and is based in Beijing, China.

Video++

Series B in 2018
Video++ provides video-streaming services for users within and outside China. It began operation in April 2014, with its headquarters in Shanghai in China.

Biocytogen

Series C in 2018
Biocytogen is a biotechnology company specializing in the development of gene-engineered animal models for life sciences research. Founded in 2008 and headquartered in Beijing, with additional locations in the United States, Biocytogen offers a range of preclinical animal studies utilizing various advanced models, including gene humanized and patient-derived xenograft (PDX) models. Its product portfolio features numerous genetically modified mouse and rat models designed for research in areas such as tumor immunity, autoimmunity, and pharmacology. The company also provides customized gene-targeting services, phenotype analysis, and an antibody research and development platform. By integrating resources from both China and the U.S., Biocytogen aims to be a leading supplier of gene-targeted animal models and services globally.

Bangsun Technology

Series B in 2018
Hangzhou Bangsun Financial Information Technology Ltd. develops online payment security software to domestic Internet trading companies and online financial institutions. The company offers solution, such as banking solution, tripartite payment solution, bank card solution, credit card, securities, and e-government solutions. In addition, it provides products, including real time transaction anti-fraud, Internet credit, flow cube, machine learning system and model, device fingerprint, machine defense service, Internet risk data service, and anti-money laundering service. Hangzhou Bangsun Financial Information Technology Ltd. was founded in 2010 and is based in Hangzhou, China.

DigiHuman

Post in 2018
Shandong Digihuman Technology Co.,Inc designs and develops digital human body system and application software solutions. The company offers China Digihuman Anatomy System, digital medical image processing, human body big data, and digital medical teaching platform. It offers various solutions, including medical education, life science education, clinical treatment, Digihuman cloud platform. The company serves the medicine, clinics, science popularization, aviation, and military fields. Shandong Digihuman Technology Co.,Inc was formerly known as Shandong Yichuang Electronics Co., Ltd. and changed its name to Shandong Digihuman Technology Co.,Inc in August 2015. The company was founded in 2002 and is based in Jinan City, China.

KBP Biosciences

Series A in 2018
KBP Biosciences Co., Ltd. is a biotechnology company based in Jinan, China, with additional offices in Beijing, Japan, and the United States. Founded in 2002, the company focuses on the research and development of drugs targeting infectious and metabolic diseases. Its comprehensive research platform employs structure-based drug design, in vitro and cell-based biological screening, and pharmacodynamic and pharmacokinetic evaluation, alongside ADME profiling and pre-clinical animal pharmacology and toxicity analysis. KBP Biosciences also offers services related to the transfer of new drugs, licensing, and intellectual property protection, which includes patent scope analysis, novelty analysis, and patent writing and filing. The organization is committed to delivering innovative therapies to address unmet medical needs.
Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. is located in Ningbo, Zhejiang, China and is part of the Computer Systems Design and Related Services Industry. There are 4 companies in the Zhejiang Bluetron Industrial Internet Information Technology Co., Ltd. corporate family.

OMNI

Series C in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

Enmotech

Series B in 2017
Enmotech (Beijing) Information Technology Co., Ltd. provides solutions and professional services for data/database systems and related areas. The company’s products and services include security, performance optimization, integration, and others. It also offers technical services, such as distributed architecture, high availability disaster recovery, SQL audit, operation and maintenance, performance monitoring, professional training, and data model optimization. In addition, the company provides software that comprise Bethune, an IT system health automated inspection platform; zCloud database cloud service management platform; SQM – SQL quality control platform; zData database machine; and MyData, an automated operation and maintenance management platform. It serves customers in financial services, communication operation, energy transportation, government/public utility, and manufacturing/trade markets. The company was founded in 2009 and is based in Beijing, China.

ECTEK

Post in 2017
Changzhou ECTEK Automotive Systems CO., Ltd researches, develops, manufactures, and sells electrical automotive products. The company offers vehicle control systems, test bench and control systems, electronic control unit (ECU) test systems, and diesel electric control systems. Changzhou ECTEK Automotive Systems CO., Ltd supplies its products to marine, locomotive, construction machinery, and other power industries. The company was founded in 2005 and is based in Changzhou, China.

OMNI

Series B in 2017
Shanghai OMNI Pharmaceutical Technology Co., Ltd. researches, develops, and manufactures respiratory pharmaceutical products in China. It offers contract manufacturing organizations (CMO) and clinical research organizations (CRO) services of difficult dosage forms. The company was founded in 2006 and is based in Shanghai, China.

Cambricon Technologies

Series A in 2017
Cambricon Technologies Corporation Limited creates core processor chips for various types of intelligent cloud servers, intelligent edge devices, and intelligent terminals. It offers terminal intelligent processor IPs, smart accelerator cards, and edge artificial intelligence acceleration cards; and Cambricon NeuWare, a software development platform for its cloud, edge, and end intelligent processor products. The company was founded in 2016 and is based in Beijing, China.

Eucure Biopharma

Series A in 2017
Eucure (Beijing) Biopharma Co., Ltd is a biotechnology company based in Beijing, China, specializing in the discovery and development of immuno-oncology targeted antibodies, particularly focusing on immune checkpoints. Founded in 2016, Eucure offers services including antibody production, in vivo drug efficacy testing, and in vitro efficacy evaluations. The company has a robust pipeline featuring multiple drug candidates, including YH-001 through YH-008. Several of these products have progressed to the CMC stage and have applied for clinical trials as of 2019. Eucure's mission is to create innovative antibody treatments aimed at improving survival rates for patients with tumors, reflecting its commitment to advancing cancer therapy. As of August 2020, Eucure operates as a subsidiary of Beijing Biocytogen Co., Ltd.

HiGo

Angel Round in 2017
HiGo is a developer of intelligent driving control systems that aims to provide comprehensive solutions for autonomous vehicles. The company specializes in hardware, focusing on a central computing platform and chassis domain control platform. HiGo has positioned itself as a leader in the industry by launching self-driving electric sweepers designed for low-speed and fixed scenarios in China. This initiative not only showcases the company's technological capabilities but also contributes to the advancement of the autonomous driving sector.

Realmax

Series A in 2017
Realmax Technology Limited is a high tech company in augmented reality (AR).

Feilongyu

Angel Round in 2017
Guizhou Feilongyu Industrial Group Co., Ltd. engages in the production and sales of water for consumption. The company was founded in 1993 and is based in Guiyang, China.

Skyguard

Series A in 2017
Beijing SkyGuard Network Security Technologies LLC provides network information security technology services. The company was founded in 2015 and is based in Beijing, China.

Biocytogen

Series B in 2017
Biocytogen is a biotechnology company specializing in the development of gene-engineered animal models for life sciences research. Founded in 2008 and headquartered in Beijing, with additional locations in the United States, Biocytogen offers a range of preclinical animal studies utilizing various advanced models, including gene humanized and patient-derived xenograft (PDX) models. Its product portfolio features numerous genetically modified mouse and rat models designed for research in areas such as tumor immunity, autoimmunity, and pharmacology. The company also provides customized gene-targeting services, phenotype analysis, and an antibody research and development platform. By integrating resources from both China and the U.S., Biocytogen aims to be a leading supplier of gene-targeted animal models and services globally.

Eucure Biopharma

Series A in 2016
Eucure (Beijing) Biopharma Co., Ltd is a biotechnology company based in Beijing, China, specializing in the discovery and development of immuno-oncology targeted antibodies, particularly focusing on immune checkpoints. Founded in 2016, Eucure offers services including antibody production, in vivo drug efficacy testing, and in vitro efficacy evaluations. The company has a robust pipeline featuring multiple drug candidates, including YH-001 through YH-008. Several of these products have progressed to the CMC stage and have applied for clinical trials as of 2019. Eucure's mission is to create innovative antibody treatments aimed at improving survival rates for patients with tumors, reflecting its commitment to advancing cancer therapy. As of August 2020, Eucure operates as a subsidiary of Beijing Biocytogen Co., Ltd.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a prominent biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibody drug candidates. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in treating multiple cancers and is featured on the National Reimbursement Drug List. Innovent has developed several other promising candidates, including biosimilars and bispecific antibodies for conditions such as non-Hodgkin’s lymphoma, autoimmune diseases, and advanced solid tumors. The company has established strategic collaborations with major global pharmaceutical firms, enhancing its research and development capabilities. Founded in 2011, Innovent has a strong management team with extensive experience in biologics, and it continues to expand its portfolio of therapeutic options while maintaining a commitment to innovation in the biopharmaceutical industry.
Twenty First Century Aerospace Technology Co., Ltd operates commercial earth observation (EO) satellites, and provides data and information services. The company operates EO small satellites, including the 1m optical EO small satellite constellation, and satellite control and image tasking and receiving stations. It provides products and services for the entire space geo-information value chain that range from satellite procurement/financing, satellite housekeeping, payload and satellite resources management, tasking, data acquisition, image processing, hosting/archiving, data management/distribution, multiple satellite source integration through its Web portal, and geo-information services to application software development and integrated solutions. The company offers imaging data, including programmed and archiving data; value added images, geo-information services, and spatial remote sensing services; image data processing software, database, Web portal development, smart satellite resource management and operation, and automatic and intelligent tasking software development, as well as direct image receiving. Its geo-information services cover a range of information products and services; including land cover theme imagery, change investigation, data statistics and analysis, 3D simulation, and professional consultancy for spatial information applications to serve government administration, public services, and commercial markets. The company also provides information extraction, operational monitoring, system platform, and ground station services. Its solutions are used for intelligence city management, living resources, energy and natural resources, eco-environment, disaster and emergency response, and industrial applications. The company was founded in 2001 and is based in Beijing, China.

Huangdi

Series B in 2015
Guizhou Huangdi Technology Co., Ltd. manufactures emission controlling solutions for tunnel and cave machines, ships, forklifts, buses, trucks, generation units, explosion-proof mining machines, non-explosion-proof mining machines, and special vehicles. Its products include diesel particulate filters, ART type active regeneration particular filter systems, fuel borne catalysts, and diesel particulate filter cleaners. The company partners with engine makers and OEMs in the United Kingdom, France, Italy, Portugal, Singapore, the United States, Venezuela, the United Arab Emirates, Indonesia, Hong Kong, Macau, and internationally. Guizhou Huangdi Technology Co., Ltd. was founded in 2008 and is based in Guiyang City, China.

Zhejiang Xianju Pharmaceutical

Funding Round in 2001
Zhejiang Xianju Pharmaceutical Co., Ltd., founded in 1972 and based in Xianju, China, specializes in the manufacture and sale of steroid drugs and hormone medicines. The company provides a wide range of active pharmaceutical ingredients, including corticosteroids, sex hormones, and medications for anesthesia and muscle relaxation, with over 200 varieties of drugs available. Its product offerings include raw materials and finished formulations, which are available in various forms such as tablets, capsules, injections, and creams. All of Xianju Pharmaceutical's products meet Good Manufacturing Practice (GMP) standards, ensuring quality and safety. The company has established long-term collaborations with more than twenty prestigious scientific research institutes and universities in China, enhancing its research and development capabilities.